Late Phase Solutions Europe is an Independent International Expert in Real World Data and Late Phase Development of Orphan Drugs
Late Phase Solutions Europe AB provides you with strategic and operational guidance on Late Phase Drug Development with a focus on Real World Data on orphan drugs both from an international as well as national perspective.
Late Phase Solutions Europe has an in-depth expertise in orphan diseases and drugs as well as designing and managing patient registries within the orphan drug area and has a proven track record of successful collaboration with patient registry stakeholders (patient organizations, treating physicians, authorities, payers) by assuring registry output fulfills their different needs as well as the ability to connect pharma business opportunities with patient registry design, management and outcome.
Our offer includes strategic advice, guidance and project management on processes and activities related to Orphan Drug Development and Market Access.
Our Customers
Our customers are big pharma companies as well as small startup pharma and biotech companies all with a focus on patients with rare diseases and the high degree on unmet medical needs within this area.
More about us
To know more about us and how we best can meet your needs please contact us.